Hot Deals:
5 star business 500.00 (-0.79 %) a v thomas 11,770.00 (-0.25 %) amol minechem 620.00 (1.64 %) anand i-power 20.00 anglo french 370.00 (-2.37 %) aricent 575.00 (0.88 %) arohan 181.00 (0.56 %) assam carbon 243.00 (-2.80 %) associated pigments limited 44.00 (-2.22 %) atlas copco 5,500.00 (1.85 %) auckland 135.00 (-3.57 %) axles 135.00 (-3.57 %) b9 bira 772.00 (0.26 %) balmer lawrie van leer 300.00 bharat hotels 162.00 (1.25 %) bikaji foods 390.00 (1.04 %) boat 850.00 (-3.41 %) c & s electric 490.00 (4.26 %) capgemini 11,000.00 (-2.22 %) care health 140.00 (-1.41 %) carrier aircon 255.00 (-0.39 %) cial 183.00 (1.67 %) csfbl 275.00 (-1.79 %) csk 160.00 (3.23 %) dalmia bharat refractories 81.00 (-4.71 %) east india pharmaceutical 39.00 (-2.50 %) eaton fluid 303.00 (1.00 %) electronica plastic 4,100.00 (-4.65 %) elgi ultra 400.00 elofic 1,909.00 (0.47 %) epiroc 1,224.00 (-2.08 %) esl steel 31.00 (-3.13 %) fincare 74.00 (1.37 %) fincare business services 43.00 fino paytech 140.00 (-3.45 %) frick india 3,806.00 (0.16 %) gkn drive 1,051.00 (0.10 %) godavari biorefineries 71.00 (1.43 %) hdbfsl 600.00 (-2.44 %) hdfc ergo 363.80 hdfc securities 11,500.00 (-3.36 %) hella india 181.00 (0.56 %) hero fincorp 714.00 (-1.24 %) hicks 2,100.00 (-2.55 %) hira ferro 121.00 (-3.20 %) honeywell electrical 3,555.00 (-1.25 %) icex 5.01 (0.20 %) incred financial 100.00 india carbon 1,060.00 (-3.64 %) india exposition mart 146.00 (0.69 %) indian potash limited 1,405.00 (0.36 %) indofil industries 700.00 (-1.41 %) infinite computer 700.00 inkel 12.95 (-0.38 %) ixigo 110.00 (-0.90 %) jana sfbl 75.00 kial 107.00 (-2.73 %) kurlon enterprise 640.00 (-3.03 %) kurlon limited 426.00 (-3.18 %) lava 123.00 (1.65 %) manipal hfsl 72.50 (0.69 %) manjushree technopack 1,010.00 (-3.81 %) martin and harris 1,980.00 (-1.98 %) merino 2,900.00 (-4.92 %) minosha 280.00 (-3.45 %) mitsubishi heavy industries 355.00 (1.43 %) mkcl 415.00 (1.22 %) mobikwik 470.00 (3.30 %) mohan meakin 1,212.00 (1.00 %) mohfl 11.90 (-1.65 %) msei 1.00 (-4.76 %) msil 56.00 (3.70 %) ncdex 275.00 ncl buildtek 185.00 (-2.63 %) ncl holdings 47.50 (1.06 %) nse 3,050.00 (-1.61 %) orbis financial 67.00 (3.08 %) oswal minerals 64.00 (-1.54 %) otis 3,800.00 (-2.56 %) oyo rooms 99.00 (-1.00 %) panasonic appliances 306.00 (0.33 %) panasonic avc 29.10 (0.34 %) paymate india 600.00 (-3.38 %) pharm easy 38.00 (-2.56 %) philips domestic 550.00 (3.77 %) philips india 1,100.00 (1.85 %) pnb metlife 70.00 proyuga adtech 25.00 ramaraju surgical 530.00 (0.57 %) reliance general insurance 340.00 resins plastics 414.00 (1.97 %) ring plus 370.00 (1.37 %) rrl 3,000.00 (3.45 %) sabmiller 350.00 (-2.78 %) satya micro 200.00 scottish assam 565.00 (-0.88 %) shriram life 251.00 (0.40 %) signify 1,050.00 (-6.75 %) smile microfin 56.00 (1.82 %) sri vishnu shankar 510.00 (-2.30 %) sterlite power 855.00 (0.59 %) studds 1,155.00 (0.43 %) t stanes 675.00 tata tech 5,200.00 (-0.95 %) tmbl 530.00 (-1.85 %) trl krosaki 1,224.00 (-2.16 %) utkarsh coreinvest 127.00 (-2.31 %) vikram solar 55.50 (-0.89 %) xerox 243.00 (1.25 %)
×

east india pharmaceutical works Limited

39.00
-2.50 %
Scrip Name
EAST INDIA PHARMACEUTICAL
ISIN No.
INE254X01017
PAN No.
AAACE5779P
Face Value
10
No. of Outstanding Shares
6,674,858
Market Capitalization
26.03 Crore

EAST INDIA PHARMACEUTICAL WORKS LIMITED UNLISTED SHARE 


East India Pharmaceutical Works Limited (EIPW) is one of the oldest pharmaceutical companies in India, Founded on 27 April 1936, it is involved in the Manufacturing of healthcare Products. It is registered at the registrar of companies in Kolkata. Authorized equity share capital of company is Rs. 10,00,00,000 and paid-up capital is Rs. 6,67,45,180.

The Company has over 87 years of experience and has a focused “people-centric approach” which enabled it to evolve with ever-changing healthcare needs and it offers high-quality advanced medicines for modern-day health complexities.


Along with its high-quality products and experienced medical and research team, backed by the most advanced and precise equipment and infrastructure, the company ensures international quality standards at every stage of production. East India Pharmaceutical is focused to use cost-effective processes to produce high-volume formulations. The company has achieved GMP, WHO-GMP, and GLP certifications.


INCORPORATION DETAILS

CIN

U24231WB1936PLC008598

Registration Date

27 April 1936

Company Name

EAST INDIA PHARMACEUTICAL WORKS LIMITED

Email Address

dcs@eastindiapharma.org

Category/Sub-category of the Company

Company Limited by Shares/Non-Government Company

Class of Company

Public

Registration Number

8598

Banker

Punjab National Bank

Address of the Registered office & contact details

6, Nandalal Bose Sarani, Kolkata 700 071

Statutory Auditors

M/s APS Associates Chartered Accountants

Cost Auditors

M/s DGM & Associates Cost Accountants

Company Secretary

Ms. Jayeeta Sarkar

Registrar and Share Transfer Agent

C B Management Services (P) Ltd. P-22, Bondel Road, Kolkata - 700 019

Listing Status

Unlisted


PARTICULAR OF SUBSIDIARY COMPANIES

Name of the Company

Subsidiary

% of shares held

Qasar Healthcare Private Limited

Subsidiary

99.5%


BOARD OF DIRECTORS

Mr. Debarshi Duttagupta (Managing Director)

Mrs. Satarupa Mukherjee (Executive Director)

Prof. (Dr.) Ranabir Mukherjee

Mr. Probir Roy (Chairman)

Mr. Dilip Samadar (Member)

Prof. (Dr.) Suman Kumar Mukerjee

Mr. Sukamal Chandra Basu (Member)

Mr. Chiraranjan Addy

Prof. (Dr.) Himadri Sengupta

Dr. Abhijit Banerjee

Dr.Tapas Raychaudhury

Mrs. Indrani Sen

Mrs. Sanghamitra Duttagupta

Mrs. Trishna Guha

 

Principal Business Activities of the Company

Name & Description of main products/services

NIC Code of the Product /service

% to total turnover of the company

Manufacture of bulk drugs, Manufacture & sale of formulations & Trading Activities

210

100%

 

SHAREHOLDING PATTERN

(As of 31-03-2021)

S. No.

Shareholder’s Category

No. of Shares

% of total Shares of the company

1

PROMOTERS

20,09,361

30.11%

2

PUBLIC

46,65,497

69.89%

 

Total

66,74,858

100%


Industry Outlook

The company is one of the oldest pharmaceutical companies in India that develops, manufactures, and markets high-quality medicines. The company has two manufacturing plants, one in Durgapur and one in Kolkata, with cutting-edge production facilities. The rapid spread of the COVID-19 pandemic had a significant impact on global economic activity. In India, like other countries around the world, has been severely impacted. IMF forecasts a 4.5 percent contraction in India for 2021. Finance Minister announced an additional outlay of Rs. 1,97,000 crore (USD 26,578.3 million) for the pharmaceutical Production Linked Incentive (PLI) scheme.


FY 2020-2021 Highlights of Company

  • Turnover at Rs. 1,72,69,64,586
  • Profit before Tax at Rs. 5,50,87,817

PROFIT & LOSS STATEMENT OF EAST INDIA PHARMACEUTICAL WORKS LIMITED (In Rs.)

(As of 31-03-2019 to 31-03-2021)

Particular

2021

2020

2019

Revenue




Revenue from Operations

1,72,67,84,326

1,58,39,11,504

1,61,28,72,834

Other Income

1,80,260

15,71,901

12,35,696

Total Revenue

1,72,69,64,586

1,58,54,83,405

1,61,41,08,530

Expenses




Cost of materials consumed

49,96,34,132

46,57,72,212

45,62,48,199

Purchases of Traded Goods

1,71,87,443

1,77,56,384

1,26,64,335

Finished goods, Work-in-Progress and Traded Goods

2,83,85,036

(4,58,18,931)

(1,19,97,983

Employee Benefits Expenses

63,98,08,743

59,20,38,256

54,00,90,712

Finance Costs

5,05,30,470

5,55,92,371

5,69,63,781

Depreciation and Amortisation Expenses

2,60,54,248

3,03,52,719

1,63,96,508

Research and Development Expenses

1,35,43,417

1,36,07,606

1,18,54,490

Other Expenses

39,67,63,227

42,54,57,542

51,58,75,286

Total Expenses

1,67,19,06,716

1,55,47,58,159

1,59,80,95,328

Profit / (Loss) Before Tax

5,50,57,870

3,07,25,246

1,60,13,202

Tax Expenses




         Current tax

2,50,00,000

1,00,00,000

45,00,000

         Deferred tax

(65,97,317)

(45,64,268)

(26,25,388)

         Tax Adj. of earlier Years

51,99,659

52,41,291

14,72,927

Total

2,36,02,342

1,06,77,023

33,47,539

Profit / (Loss) For the Year 

3,14,55,528

2,00,48,223

1,26,65,663

Earnings Per Equity Shares




    Earnings Per Equity Shares (Basic)

4.71

3.00

1.90

    Earnings Per Equity Shares (Diluted)

4.71

3.00

1.90


BALANCE SHEET OF EAST INDIA PHARMACEUTICAL WORKS LIMITED (In Rs.)

(As of 31-03-2019 to 31-03-2021)

PARTICULARS

2021

2020

2019

EQUITY AND LIABILITIES:




Share Capital

6,67,45,179

6,67,45,179

6,67,45,179

Reserves and Surplus

40,56,16,066

38,08,35,247

36,48,10,162

Minority Interest

(45,888)

(45,738)

(45,635)

Non-Current Liabilities:




Long-Term Borrowings

4,23,36,281

32,67,440

12,40,426

Long-Term Provisions

8,14,91,000

6,43,20,000

5,51,46,000

Current Liabilities:




Short-Term Borrowings

32,19,00,853

35,31,62,674

31,40,23,439

Trade Payables

34,39,64,616

34,94,48,075

30,64,48,374

Other Current Liabilities

19,62,03,669

17,44,73,972

17,31,13,522

Short-Term Provisions

3,35,77,000

1,65,09,000

90,90,000

TOTAL LIABILITIES

1,49,17,88,776

1,40,87,15,849

1,29,05,71,467

ASSETS




Non-Current Assets




Fixed Assets




      Tangible Assets

15,41,09,850

17,06,81,797

9,63,38,731

      Intangible Assets

7,82,364

8,26,060

9,34,088

      Capital work-in-progress

37,32,327

66,27,594

9,78,80,503

Deferred Tax Assets (Net)

4,89,77,722

4,23,80,405

3,78,16,137

Long-Term Loans and Advances

71,16,873

1,00,86,375

90,98,712

Current Assets




Inventories

34,94,30,415

37,83,84,071

26,87,61,911

Trade Receivables

70,98,01,337

57,00,98,674

53,42,38,157

Cash and Cash Equivalents

15,67,73,363

12,68,82,571

16,89,35,815

Short-Term Loans and Advances

6,10,64,525

10,07,48,302

7,45,67,413

Other Current Assets

NIL

20,00,000

20,00,000

TOTAL ASSETS

149,17,88,776

140,87,15,849

129,05,71,467


DIVIDEND AND RETAINED EARNINGS

(As of 31-03-2019 to 31-03-2021)

Particulars

2021

2020

2019

Dividend (in Rs.)

1.25

1.00

0.50

Retained Earnings

248.11

160.46

126.77


PERFORMANCE OF THE COMPANY

Revenue from operation increased from Rs. 1,58,39,11,504 in FY 2020 to Rs. 1,72,67,84,326 in FY 2021, showing a growth of 9.03% as compared to the previous financial year.


Finance Cost has decreased from Rs. 5,55,92,371 in FY 2020 to Rs.  5,05,30,470 in FY 2021, showing a decline of 9.11% as compared to the previous financial year.


In FY 2021, Company’s Net profit stood at Rs. 3,14,55,528 as against to net profit of Rs. 2,00,48,223 in FY 2020 showing a growth of 56.9% as compared to the previous financial year. 


The Current Ratio of the company as of 31st March 2021 was 1.43.

 

The debt to equity ratio of the company as of 31st March 2021 was 3.16.


The Company paid a dividend of Rs. 1.25 in the financial year 2020-2021



Powered by Froala Editor

Annual Reports

2020-21

Download

2019-20

Download

2018-19

Download

2017-18

Download

2016-17

Download

2015-16

Download
Wealth Wisdom - WWIPL
Support Megha Support Neha Support Pallavi